Pfizer Settles Lipitor Battles With Ranbaxy
Pfizer Inc. has reached an agreement with generics maker Ranbaxy Laboratories Ltd. to settle most of the worldwide patent litigation between the two companies over the blockbuster cholesterol-reducing treatment Lipitor....To view the full article, register now.
Already a subscriber? Click here to view full article